↓ Skip to main content

Ageing and Dementia

Overview of attention for book
Cover of 'Ageing and Dementia'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Anti-oxidants and cognitive function: a review of clinical and epidemiologic studies
  3. Altmetric Badge
    Chapter 2 Brain abnormalities in the elderly: frequency and predictors in the United States (the Cardiovascular Health Study)
  4. Altmetric Badge
    Chapter 3 Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam study
  5. Altmetric Badge
    Chapter 4 The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates
  6. Altmetric Badge
    Chapter 5 Cognitive correlates of cerebral white matter changes
  7. Altmetric Badge
    Chapter 6 Concepts on the prognostic significance of white matter changes
  8. Altmetric Badge
    Chapter 7 Difficulties in the clinical diagnosis of vascular dementia and dementia of the Alzheimer type — comparison of clinical classifications
  9. Altmetric Badge
    Chapter 8 Problems of differential diagnosis between depressive pseudodementia and Alzheimer’s disease
  10. Altmetric Badge
    Chapter 9 The neuropathological diagnosis of Alzheimer disease
  11. Altmetric Badge
    Chapter 10 The progression of the lesions in Alzheimer disease: insights from a prospective clinicopathological study
  12. Altmetric Badge
    Chapter 11 Evolution of neuronal changes in the course of Alzheimer’s disease
  13. Altmetric Badge
    Chapter 12 The cytoskeleton in Alzheimer disease
  14. Altmetric Badge
    Chapter 13 Mechanisms of synaptic pathology in Alzheimer’s disease
  15. Altmetric Badge
    Chapter 14 Proteolytic processing of Alzheimer’s disease associated proteins
  16. Altmetric Badge
    Chapter 15 Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles
  17. Altmetric Badge
    Chapter 16 Presenilins and Alzheimer’s disease: the role of Aβ42
  18. Altmetric Badge
    Chapter 17 Biological markers for the diagnosis of Alzheimer’s disease
  19. Altmetric Badge
    Chapter 18 Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer’s disease
  20. Altmetric Badge
    Chapter 19 Cerebrospinal fluid levels of Aβ42 and tau: potential markers of Alzheimer’s disease
  21. Altmetric Badge
    Chapter 20 Combination of the different biological markers for increasing specificity of in vivo Alzheimer’s testing
  22. Altmetric Badge
    Chapter 21 Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementia
  23. Altmetric Badge
    Chapter 22 Current diagnostic methods and outcome variables for clinical investigation of Alzheimer’s disease
  24. Altmetric Badge
    Chapter 23 Perspectives in clinical Alzheimer’s disease research and the development of antidementia drugs
  25. Altmetric Badge
    Chapter 24 The role of glutamate in dementia
  26. Altmetric Badge
    Chapter 25 Neurotrophic activities and therapeutic experience with a brain derived peptide preparation
  27. Altmetric Badge
    Chapter 26 Brain-derived peptides reduce the size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats
  28. Altmetric Badge
    Chapter 27 The influence of Cerebrolysin® and E021 on spatial navigation of 24-month-old rats
  29. Altmetric Badge
    Chapter 28 Molecular regulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived factors
  30. Altmetric Badge
    Chapter 29 Antioxidant systemic effect of short-term Cerebrolysin® administration
  31. Altmetric Badge
    Chapter 30 Can Cerebrolysin® influence chronic deterioration of spatial learning and memory?
  32. Altmetric Badge
    Chapter 31 Cerebrolysin® protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia
  33. Altmetric Badge
    Chapter 32 Further evidence that Cerebrolysin® protects cortical neurons from neurodegeneration in vitro
  34. Altmetric Badge
    Chapter 33 Influence of BDNF and FCS on viability and programmed cell death (PCD) of developing cortical chicken neurons in vitro
  35. Altmetric Badge
    Chapter 34 Dose-dependent effects of Cerebrolysin® on EEG and short term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia
Attention for Chapter 33: Influence of BDNF and FCS on viability and programmed cell death (PCD) of developing cortical chicken neurons in vitro
Altmetric Badge

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Influence of BDNF and FCS on viability and programmed cell death (PCD) of developing cortical chicken neurons in vitro
Chapter number 33
Book title
Ageing and Dementia
Published by
Springer, Vienna, January 1998
DOI 10.1007/978-3-7091-6467-9_33
Book ISBNs
978-3-21-183114-4, 978-3-70-916467-9
Authors

K. Reinprecht, B. Hutter-Paier, K. Crailsheim, M. Windisch

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Professor 2 33%
Researcher 2 33%
Student > Ph. D. Student 1 17%
Student > Postgraduate 1 17%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Computer Science 1 17%
Neuroscience 1 17%
Medicine and Dentistry 1 17%
Unknown 2 33%